A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer


Ward, S; Morris, E; Bansback, N; Calvert, N; Crellin, A; Forman, D; Larvin, M; Radstone, D; (2001) A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer. Health technology assessment (Winchester, England), 5 (24). pp. 1-70. ISSN 1366-5278

[img]
Preview
Text - Published Version
License:

Download (458kB) | Preview
Item Type: Article
Keywords: Antimetabolites, Antineoplastic/*therapeutic use, Cost-Benefit Analysis, Deoxycytidine/*analogs & derivatives/*therapeutic use, Fluorouracil/therapeutic use, Humans, Pancreatic Neoplasms/*drug therapy, Quality of Life, Antimetabolites, Antineoplastic, therapeutic use, Cost-Benefit Analysis, Deoxycytidine, analogs & derivatives, therapeutic use, Fluorouracil, therapeutic use, Humans, Pancreatic Neoplasms, drug therapy, Quality of Life
Faculty and Department: Faculty of Public Health and Policy > Dept of Health Services Research and Policy
PubMed ID: 11701098
URI: http://researchonline.lshtm.ac.uk/id/eprint/10369

Statistics


Download activity - last 12 months
Downloads since deposit
1,139Downloads
287Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item